These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36303089)

  • 1. Ketogenic diet therapy in children with epilepsy caused by SLC2A1 mutations: a single-center single-arm retrospective study.
    Wang YY; Zhou YQ; Luo LJ; Wang CJ; Shen N; Li H; Wang JW
    World J Pediatr; 2024 May; 20(5):517-524. PubMed ID: 36303089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classic Ketogenic Diet and Modified Atkins Diet in SLC2A1 Positive and Negative Patients with Suspected GLUT1 Deficiency Syndrome: A Single Center Analysis of 18 Cases.
    Ruiz Herrero J; Cañedo Villarroya E; González Gutiérrez-Solana L; García Alcolea B; Gómez Fernández B; Puerta Macfarland LA; Pedrón-Giner C
    Nutrients; 2021 Mar; 13(3):. PubMed ID: 33806661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical characteristics and ketogenic diet therapy of glucose transporter type 1 deficiency syndrome in children: a multicenter clinical study].
    Yu LF; Zhang YQ; Duan J; Ni Y; Gong XY; Lu ZY; Liao JX; Lu XP; Shi ZN; Lei MF; Zhong JM; Zha J; Zhou SZ
    Zhonghua Er Ke Za Zhi; 2020 Nov; 58(11):881-886. PubMed ID: 33120458
    [No Abstract]   [Full Text] [Related]  

  • 4. Occurrence of GLUT1 deficiency syndrome in patients treated with ketogenic diet.
    Ramm-Pettersen A; Nakken KO; Haavardsholm KC; Selmer KK
    Epilepsy Behav; 2014 Mar; 32():76-8. PubMed ID: 24508593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re-analysis of whole-exome sequencing data reveals a novel splicing variant in the SLC2A1 in a patient with GLUT1 Deficiency Syndrome 1 accompanied by hemangioma: a case report.
    Bozkurt T; Alanay Y; Isik U; Sezerman U
    BMC Med Genomics; 2021 Jul; 14(1):197. PubMed ID: 34332575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Favourable response to ketogenic dietary therapies: undiagnosed glucose 1 transporter deficiency syndrome is only one factor.
    Schoeler NE; Cross JH; Drury S; Lench N; McMahon JM; MacKay MT; Scheffer IE; Sander JW; Sisodiya SM
    Dev Med Child Neurol; 2015 Oct; 57(10):969-76. PubMed ID: 25914049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of myoclonic-atonic epilepsy caused by SLC2A1 de novo mutation with ketogenic diet: A case report.
    Wei Z; Wang L; Deng Y
    Medicine (Baltimore); 2019 May; 98(18):e15428. PubMed ID: 31045803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical and genetic characteristics of glucose transporter type 1 deficiency syndrome].
    Liu YY; Bao XH; Wang S; Fu N; Liu XY; Song FY; Yang YL; Wu Y; Zhang YH; Wu JX; Jiang YW; Qin J; Wu XR
    Zhonghua Er Ke Za Zhi; 2013 Jun; 51(6):443-7. PubMed ID: 24120063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variety of symptoms of GLUT1 deficiency syndrome in three-generation family.
    Winczewska-Wiktor A; Hoffman-Zacharska D; Starczewska M; Kaczmarek I; Badura-Stronka M; Steinborn B
    Epilepsy Behav; 2020 May; 106():107036. PubMed ID: 32247176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose transporter-1 deficiency syndrome: the expanding clinical and genetic spectrum of a treatable disorder.
    Leen WG; Klepper J; Verbeek MM; Leferink M; Hofste T; van Engelen BG; Wevers RA; Arthur T; Bahi-Buisson N; Ballhausen D; Bekhof J; van Bogaert P; Carrilho I; Chabrol B; Champion MP; Coldwell J; Clayton P; Donner E; Evangeliou A; Ebinger F; Farrell K; Forsyth RJ; de Goede CG; Gross S; Grunewald S; Holthausen H; Jayawant S; Lachlan K; Laugel V; Leppig K; Lim MJ; Mancini G; Marina AD; Martorell L; McMenamin J; Meuwissen ME; Mundy H; Nilsson NO; Panzer A; Poll-The BT; Rauscher C; Rouselle CM; Sandvig I; Scheffner T; Sheridan E; Simpson N; Sykora P; Tomlinson R; Trounce J; Webb D; Weschke B; Scheffer H; Willemsen MA
    Brain; 2010 Mar; 133(Pt 3):655-70. PubMed ID: 20129935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glut1 deficiency is a rare but treatable cause of childhood absence epilepsy with atypical features.
    Soto-Insuga V; López RG; Losada-Del Pozo R; Rodrigo-Moreno M; Cayuelas EM; Giráldez BG; Díaz-Gómez E; Sánchez-Martín G; García LO; Serratosa JM;
    Epilepsy Res; 2019 Aug; 154():39-41. PubMed ID: 31035243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From splitting GLUT1 deficiency syndromes to overlapping phenotypes.
    Hully M; Vuillaumier-Barrot S; Le Bizec C; Boddaert N; Kaminska A; Lascelles K; de Lonlay P; Cances C; des Portes V; Roubertie A; Doummar D; LeBihannic A; Degos B; de Saint Martin A; Flori E; Pedespan JM; Goldenberg A; Vanhulle C; Bekri S; Roubergue A; Heron B; Cournelle MA; Kuster A; Chenouard A; Loiseau MN; Valayannopoulos V; Chemaly N; Gitiaux C; Seta N; Bahi-Buisson N
    Eur J Med Genet; 2015 Sep; 58(9):443-54. PubMed ID: 26193382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GLUT1 deficiency syndrome and ketogenic diet therapies: missing rare but treatable diseases?
    Klepper J
    Dev Med Child Neurol; 2015 Oct; 57(10):896-7. PubMed ID: 25997718
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevalence of Genetic Disorders and GLUT1 Deficiency in a Ketogenic Diet Clinic.
    Hewson S; Brunga L; Ojeda MF; Imhof E; Patel J; Zak M; Donner EJ; Kobayashi J; Salomons GS; Mercimek-Andrews S
    Can J Neurol Sci; 2018 Jan; 45(1):93-96. PubMed ID: 29144225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of non-coding variation in GLUT1 deficiency.
    Liu YC; Lee JW; Bellows ST; Damiano JA; Mullen SA; Berkovic SF; Bahlo M; Scheffer IE; Hildebrand MS;
    Dev Med Child Neurol; 2016 Dec; 58(12):1295-1302. PubMed ID: 27265003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of paediatric patients with the clinical and biochemical phenotype of glucose transporter type 1 deficiency syndrome.
    Jiménez Legido M; Cortés Ledesma C; Bernardino Cuesta B; López Marín L; Cantarín Extremera V; Pérez-Cerdá C; Pérez González B; López Martín E; González Gutiérrez-Solana L
    Neurologia (Engl Ed); 2022 Mar; 37(2):91-100. PubMed ID: 35279228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sporadic and familial glut1ds Italian patients: A wide clinical variability.
    De Giorgis V; Teutonico F; Cereda C; Balottin U; Bianchi M; Giordano L; Olivotto S; Ragona F; Tagliabue A; Zorzi G; Nardocci N; Veggiotti P
    Seizure; 2015 Jan; 24():28-32. PubMed ID: 25564316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The many faces of Glut1 deficiency syndrome.
    Tzadok M; Nissenkorn A; Porper K; Matot I; Marcu S; Anikster Y; Menascu S; Bercovich D; Ben Zeev B
    J Child Neurol; 2014 Mar; 29(3):349-59. PubMed ID: 23340081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do Glut1 (glucose transporter type 1) defects exist in epilepsy patients responding to a ketogenic diet?
    Becker F; Schubert J; Weckhuysen S; Suls A; Grüninger S; Korn-Merker E; Hofmann-Peters A; Sperner J; Cross H; Hallmann K; Elger CE; Kunz WS; Madeleyen R; Lerche H; Weber YG
    Epilepsy Res; 2015 Aug; 114():47-51. PubMed ID: 26088884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unusual sensitivity to steroid treatment in intractable childhood epilepsy suggests GLUT1 deficiency syndrome.
    Vieker S; Schmitt J; Längler A; Schmidt W; Klepper J
    Neuropediatrics; 2012 Oct; 43(5):275-8. PubMed ID: 22976442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.